Connect with us

BIOTECH

Axim Biotechnologies Inc (OTCMKTS:AXIM) Secures Patent Grant For Hemp Based Chewing Gum

Published

on

Axim Biotechnologies Inc

As the race for patent filing in marijuana space becomes more volatile, Axim Biotechnologies Inc (OTCMKTS:AXIM), recently announced securing new patent grant for its cannabinoids based chewing gum products. The U.S. Patent No. 9433601 from the company is titled Chewing Gum Compositions Comprising Cannabinoids, which contains 0.1-1% cannabinoids.

The patent space surrounding medical marijuana

While the march of companies towards legalization still has a long way to go, there is no denying the fact that the patent space surrounding medical marijuana is wide open. Innography’s patent portfolio analysis tools explain that in the medical cannabis space, there are 66 U.S. patent grants along with 62 U.S. patent applications.

Axim Biotechnologies Inc- a patent-rich company

The newly issued patent to company isn’t the only one that it has. Axim Biotechnologies Inc also has U.S. Patent No. 9023322, which was issued in 2015 and used Hemp as the pharmaceutical agent. While the earlier patent only included Hemp, the newer one also includes tetrahydrocannabinol (THC).

Apart from the chewing gum products, Axim Biotechnologies Inc also works on other Hemp products, such as topical applications (like hand cream and dermatological ointments), eye drops, mouthwash, toothpaste and more. While it is dedicatedly working on the medical marijuana segment, there is no intention to dive into the recreational market, as of now.

According to AXIM Biotech CEO George Anastassov, “We deliver a system which is just as efficient as smokable cannabis without negative effects. We’re against any type of smokable material.”

The CEO stated that Axim Biotechnologies Inc is a patent-rich company and has 20 trademarks in marijuana space. What is more interesting is that none of the company’s patents in marijuana space have been rejected so far.

Protecting intellectual property paramount to Axim Biotechnologies Inc

George Anastassov stated that protecting company’s intellectual property is paramount due to several developments underway. He added, “We make sure that before we announce anything, we have IP protection.” He also feels optimistic regarding the future of medical and recreational marijuana in the U.S.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.